http://web.archive.org/web/20150714001406id_/http://www.dailymail.co.uk/news/article-2910138/FDA-approves-pacemaker-like-appetite-zapping-implant-severely-obese-patients.html

patients and doctors can adjust the settings for the ' pacemaker - like ' device using external controllers federal regulators have approved an appetite - suppressing implant designed to treat obesity by zapping nerves that connect the stomach and the brain			1
the @entity11 uses electrodes implanted in the abdomen to stimulate the vagus nerve , which signals to the brain that the stomach is empty or full			1
patients and doctors can adjust the device settings using external controllers			1
shares of @entity20 rose in trading on wednesday after the @entity22 said it approved the device for certain patients who are severely obese			2
it 's the first medical device approved for obesity since the agency 's 2007 approval of a gastric band from @entity30			1
the @entity22 approved the device for patients 18 and older who have been unable to lose weight via a supervised weight - loss program and have a body mass index of 35 to 40 with one other obesity - related health condition , such as diabetes			2
@entity38 is an estimate of body fat based on weight and height			0
someone who is 5 - foot - 9 would be severely obese — with a @entity38 of 35 — at 240 pounds			0
the @entity11 uses electrodes implanted in the abdomen to stimulate the vagus nerve , which signals to the brain that the stomach is empty or full @entity20 said the device 's two electrodes are implanted via a minimally - invasive surgical procedure , which could make the device system a less invasive alternative to other weight - loss surgeries			1
the device has an external battery that needs to be recharged weekly			0
the @entity58 , @entity59 - based company compares it to a pacemaker			0
a company executive said the device is already approved in @entity63 and @entity64 though it is not yet on sale			1
@entity20 plans to focus on the device 's @entity67 launch , targeting sales to surgical centers			0
the company is also pursuing reimbursement from health care insurance providers			0
@entity20 stock gained 30 cents , or 25 percent , to $ 1.47 in morning trading			0
the @entity22 has approved the device for patients 18 and older who have been unable to lose weight via a supervised weight - loss program and have a body mass index of 35 to 40 with one other obesity - related health condition , such as diabetes			2

@entity11 uses electrodes implanted in the abdomen to send signals to the brain that the stomach is empty or full
patients and doctors can adjust the device settings using external controllers
first medical device approved for obesity since gastric band in 2007
device is already approved in @entity63 and @entity64 although not yet on sale

@entity22:FDA
@entity30:Ethicon
@entity20:EnteroMedics Inc.
@entity11:Maestro Rechargeable System
@entity38:BMI
@entity63:Europe
@entity67:U.S.
@entity64:Australia
@entity58:St. Paul
@entity59:Minnesota